» Articles » PMID: 19797501

Technical Details Influence the Diagnostic Accuracy of the 1 Microg ACTH Stimulation Test

Overview
Specialty Endocrinology
Date 2009 Oct 3
PMID 19797501
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To examine the factors causing inadequate cortisol responses to the 1 microg ACTH stimulation test.

Design: Random test assignment (by age and gender) at 0800 or 1600 h.

Methods: We recruited 20 healthy adults to each of the three age groups (<40 years, 40-55 years, and >55 years; half females in each group). ACTH stimulation tests were performed in an outpatient clinic at the NIH Clinical Research Center. Plasma cortisol was measured just before, and 30 and 60 min after the administration of 1 microg ACTH (1-24). The ACTH concentration in diluted and administered solutions was measured.

Results: Twenty-five volunteers (19 at 1600 h) had a subnormal cortisol response (peak cortisol 10.4-17.5 microg/dl), using a criterion <18 microg/dl (497 nmol/l), for a specificity of 58% (confidence interval (CI) 45-71%). Afternoon testing had a significant impact on failure rates (odds ratio 6.98, CI 2.17-22.43), while gender and age did not. The stock solution contained 1 microg ACTH, but after administration through tubing it contained only 0.5-0.8 microg.

Conclusions: The high rate of abnormal results, especially in the afternoon, and loss of ACTH through tubing suggest that morning testing and minimal tubing should be adopted to avoid an inappropriate diagnosis of adrenal insufficiency. Earlier time points and standardized protocols would facilitate comparison of studies.

Citing Articles

Glucocorticoid treatment and adrenal suppression in children: current view and open issues.

Improda N, Chioma L, Capalbo D, Bizzarri C, Salerno M J Endocrinol Invest. 2024; 48(1):37-52.

PMID: 39352628 PMC: 11729088. DOI: 10.1007/s40618-024-02461-9.


Determination of cortisol cut-off limits and steroid dynamics in the ACTH stimulation test: a comparative analysis using Roche Elecsys Cortisol II immunoassay and LC-MS/MS.

Okutan S, Jorgensen N, Pedersen L, Borresen S, Hilsted L, Hansen L Endocrine. 2024; 85(1):321-330.

PMID: 38460071 PMC: 11246257. DOI: 10.1007/s12020-024-03752-0.


Diagnosing and treating the elderly individual with hypopituitarism.

Corsello A, Paragliola R, Salvatori R Rev Endocr Metab Disord. 2023; 25(3):575-597.

PMID: 38150092 DOI: 10.1007/s11154-023-09870-w.


Current Screening Strategies for the Diagnosis of Adrenal Insufficiency in Children.

Bowden S Pediatric Health Med Ther. 2023; 14:117-130.

PMID: 37051221 PMC: 10084833. DOI: 10.2147/PHMT.S334576.


ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow.

Birtolo M, Antonini S, Saladino A, Zampetti B, Lavezzi E, Chiodini I Biomedicines. 2023; 11(3).

PMID: 36979883 PMC: 10045406. DOI: 10.3390/biomedicines11030904.


References
1.
Crowley S, Hindmarsh P, Honour J, Brook C . Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics. J Endocrinol. 1993; 136(1):167-72. DOI: 10.1677/joe.0.1360167. View

2.
Reimondo G, Bovio S, Allasino B, Terzolo M, Angeli A . Secondary hypoadrenalism. Pituitary. 2008; 11(2):147-54. DOI: 10.1007/s11102-008-0108-4. View

3.
Klose M, Lange M, Rasmussen A, Skakkebaek N, Hilsted L, Haug E . Factors influencing the adrenocorticotropin test: role of contemporary cortisol assays, body composition, and oral contraceptive agents. J Clin Endocrinol Metab. 2007; 92(4):1326-33. DOI: 10.1210/jc.2006-1791. View

4.
Nye E, Grice J, Hockings G, Strakosch C, Crosbie G, Walters M . Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests. J Clin Endocrinol Metab. 1999; 84(10):3648-55. DOI: 10.1210/jcem.84.10.6062. View

5.
Oelkers W, Boelke T, Bahr V . Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. J Clin Endocrinol Metab. 1988; 66(1):181-6. DOI: 10.1210/jcem-66-1-181. View